scispace - formally typeset
Search or ask a question
Author

Patrícia Sarlós

Other affiliations: University of Szeged
Bio: Patrícia Sarlós is an academic researcher from University of Pécs. The author has contributed to research in topics: Medicine & Inflammatory bowel disease. The author has an hindex of 18, co-authored 72 publications receiving 956 citations. Previous affiliations of Patrícia Sarlós include University of Szeged.


Papers
More filters
Journal ArticleDOI
31 Oct 2016-PLOS ONE
TL;DR: Analysis of a large, nationwide, prospective cohort of AP cases allowed for the identification of important determinants of severity and mortality, and evidence-based guidelines should be observed rigorously to improve outcomes in AP.
Abstract: Objective The aim of this study was to analyse the clinical characteristics of acute pancreatitis (AP) in a prospectively collected, large, multicentre cohort and to validate the major recommendations in the IAP/APA evidence-based guidelines for the management of AP Design Eighty-six different clinical parameters were collected using an electronic clinical research form designed by the Hungarian Pancreatic Study Group Patients 600 adult patients diagnosed with AP were prospectively enrolled from 17 Hungarian centres over a two-year period from 1 January 2013 Main Results With respect to aetiology, biliary and alcoholic pancreatitis represented the two most common forms of AP The prevalence of biliary AP was higher in women, whereas alcoholic AP was more common in men Hyperlipidaemia was a risk factor for severity, lack of serum enzyme elevation posed a risk for severe AP, and lack of abdominal pain at admission demonstrated a risk for mortality Abdominal tenderness developed in all the patients with severe AP, while lack of abdominal tenderness was a favourable sign for mortality Importantly, lung injury at admission was associated with mortality With regard to laboratory parameters, white blood cell count and CRP were the two most sensitive indicators for severe AP The most common local complication was peripancreatic fluid, whereas the most common distant organ failure in severe AP was lung injury Deviation from the recommendations in the IAP/APA evidence-based guidelines on fluid replacement, enteral nutrition and timing of interventions increased severity and mortality Conclusions Analysis of a large, nationwide, prospective cohort of AP cases allowed for the identification of important determinants of severity and mortality Evidence-based guidelines should be observed rigorously to improve outcomes in AP

167 citations

Journal ArticleDOI
TL;DR: The identification of disease-associated interleukin and interleucin receptor genes can provide precious insight into the genetic variations prior to disease onset in order to identify the pathways important for RA pathogenesis.
Abstract: Rheumatoid arthritis (RA) is an autoimmune disease, resulting in a chronic, systemic inflammatory disorder. It may affect many tissues and organs, but it primarily affects the flexible joints. In clinical practice patient care generates many questions about diagnosis, prognosis, and treatment. It is challenging for health care specialists to keep up to date with the medical literature. This review summarizes the pathogenesis, the polymorphisms of interleukin and interleukin genes and the standard available and possible future immunologic targets for RA treatment. The identification of disease-associated interleukin and interleukin receptor genes can provide precious insight into the genetic variations prior to disease onset in order to identify the pathways important for RA pathogenesis. The knowledge of the complex genetic background may prove useful for developing novel therapies and making personalized medicine based on the individual's genetics.

69 citations

Journal ArticleDOI
TL;DR: The rates of local complications and organ failure and maximum CRP level were significantly and dose-dependently raised by hypertriglyceridemia, which dose-dependent aggravates the severity and related complications of AP.

66 citations

Journal ArticleDOI
Andrea Párniczky1, Tamás Lantos2, Eszter Margit Tóth2, Zsolt Szakács1, Szilárd Gódi1, Roland Hágendorn1, Dóra Illés2, Balázs Koncz2, Katalin Márta1, Alexandra Mikó1, Dóra Mosztbacher1, Balázs Németh3, Dániel Pécsi1, Anikó Nóra Szabó1, Ákos Szücs4, Péter Varjú1, Andrea Szentesi2, Erika Darvasi2, Bálint Erőss1, Ferenc Izbéki, László Gajdán, Adrienn Halász, Áron Vincze1, Imre Szabó1, Gabriella Pár1, Judit Bajor1, Patrícia Sarlós1, József Czimmer1, József Hamvas, Tamás Takács2, Zoltán Szepes2, László Czakó2, Márta Varga, János Novák, Barnabás Bod, Attila Szepes, János Sümegi, Mária Papp5, Csaba Góg, Imola Török, Wei Huang6, Qing Xia6, Ping Xue6, Weiqin Li7, Wei-Wei Chen8, Natalia V Shirinskaya, Vladimir L Poluektov, Anna V Shirinskaya, Péter Jenő Hegyi9, Marian Bátovský9, Juan Armando Rodriguez-Oballe10, Isabel Miguel Salas10, Javier Lopez-Diaz, J. Enrique Domínguez-Muñoz, Xavier Molero11, Elizabeth Pando, María Lourdes Ruiz-Rebollo, Beatriz Burgueño-Gómez, Yu-Ting Chang12, Ming-Chu Chang12, Ajay Sud13, Danielle Moore13, Robert Sutton13, Amir Gougol14, Georgios I. Papachristou14, Yaroslav Susak15, Illia Olehovych Tiuliukin15, António Pedro Gomes, Maria Jesus Oliveira, David João Aparício, Marcel Tantau16, Floreta Kurti, Mila Kovacheva-Slavova, Stephanie-Susanne Stecher17, Julia Mayerle17, Goran Poropat18, Kshaunish Das, Marco Marino, Gabriele Capurso19, Ewa Małecka-Panas20, Hubert Zatorski20, Anita Gasiorowska20, Natalia Fabisiak20, Piotr Ceranowicz21, Beata Kuśnierz-Cabala21, Joana Rita Carvalho22, Samuel Raimundo Fernandes22, Jae Hyuck Chang23, Eun Kwang Choi24, Jimin Han25, Sara Bertilsson26, Hanaz Jumaa, Gabriel Sandblom27, Sabite Kacar, Minas Baltatzis28, Aliaksandr Varabei, Vizhynis Yeshy, Serge Chooklin, Andriy Kozachenko29, Nikolay Veligotsky, Péter Hegyi3 
TL;DR: The authors formulated four consensus statements to urge reduction of unjustified antibiotic treatment in acute pancreatitis and to use procalcitonin rather than WBC or CRP as biomarkers to guide decision-making.

61 citations

Journal ArticleDOI
TL;DR: The aim of the meta‐analysis was to quantify the risk of BE in the context of HPI and to estimate the prevalence of Barrett's esophagus and EAC at the same time.
Abstract: Introduction The prevalence of Helicobacter pylori infection (HPI) has been decreasing in developed countries, with an increasing prevalence of Barrett's esophagus (BE) and esophageal adenocarcinoma (EAC) at the same time. The aim of our meta‐analysis was to quantify the risk of BE in the context of HPI.

59 citations


Cited by
More filters
DOI
01 Jun 2011

618 citations

Gloria M. Petersen1, Laufey T. Amundadottir2, Charles S. Fuchs3, Peter Kraft3, Rachael Z. Stolzenberg-Solomon2, Kevin B. Jacobs4, Kevin B. Jacobs2, Alan A. Arslan5, H. Bas Bueno-de-Mesquita6, Steven Gallinger7, Myron D. Gross8, Kathy J. Helzlsouer9, Elizabeth A. Holly10, Eric J. Jacobs11, Alison P. Klein12, Andrea Z. LaCroix13, Donghui Li14, Margaret T. Mandelson13, Sara H. Olson14, Harvey A. Risch15, Wei Zheng16, Demetrius Albanes2, William R. Bamlet1, Christine D. Berg2, Marie-Christine Boutron-Ruault17, Julie E. Buring3, Paige M. Bracci10, Federico Canzian18, Sandra Clipp12, Michelle Cotterchio7, Mariza de Andrade1, Eric J. Duell, J. Michael Gaziano3, J. Michael Gaziano19, Edward Giovannucci3, Michael Goggins12, Göran Hallmans20, Susan E. Hankinson3, Manal Hassan14, Barbara V. Howard21, David J. Hunter3, Amy K. Hutchinson2, Amy K. Hutchinson4, Mazda Jenab, Rudolf Kaaks18, Charles Kooperberg13, Vittorio Krogh, Robert C. Kurtz22, Shannon M. Lynch2, Robert R. McWilliams1, Julie B. Mendelsohn2, Dominique S. Michaud22, Dominique S. Michaud3, Hemang Parikh2, Alpa V. Patel11, Petra H.M. Peeters6, Petra H.M. Peeters22, Aleksandar Rajkovic23, Elio Riboli24, Laudina Rodríguez, Daniela Seminara2, Xiao-Ou Shu16, Gilles Thomas25, Gilles Thomas2, Anne Tjønneland, Geoffrey S. Tobias2, Dimitrios Trichopoulos3, Dimitrios Trichopoulos26, Stephen K. Van Den Eeden27, Jarmo Virtamo28, Jean Wactawski-Wende29, Zhaoming Wang4, Zhaoming Wang2, Brian M. Wolpin3, Herbert Yu15, Kai Yu2, Anne Zeleniuch-Jacquotte5, Joseph F. Fraumeni2, Robert N. Hoover2, Patricia Hartge2, Stephen J. Chanock22, Stephen J. Chanock30, Stephen J. Chanock2 
01 Jan 2010
TL;DR: This study has identified common susceptibility loci for pancreatic cancer that warrant follow-up studies and identified eight SNPs that map to three loci on chromosomes 13q22.1, 1q32.1 and 5p15.1 that are associated with multiple cancers.
Abstract: We conducted a genome-wide association study of pancreatic cancer in 3,851 affected individuals (cases) and 3,934 unaffected controls drawn from 12 prospective cohort studies and 8 case-control studies. Based on a logistic regression model for genotype trend effect that was adjusted for study, age, sex, self-described ancestry and five principal components, we identified eight SNPs that map to three loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Two correlated SNPs, rs9543325 (P = 3.27 x 10(-11), per-allele odds ratio (OR) 1.26, 95% CI 1.18-1.35) and rs9564966 (P = 5.86 x 10(-8), per-allele OR 1.21, 95% CI 1.13-1.30), map to a nongenic region on chromosome 13q22.1. Five SNPs on 1q32.1 map to NR5A2, and the strongest signal was at rs3790844 (P = 2.45 x 10(-10), per-allele OR 0.77, 95% CI 0.71-0.84). A single SNP, rs401681 (P = 3.66 x 10(-7), per-allele OR 1.19, 95% CI 1.11-1.27), maps to the CLPTM1L-TERT locus on 5p15.33, which is associated with multiple cancers. Our study has identified common susceptibility loci for pancreatic cancer that warrant follow-up studies.

494 citations

Journal ArticleDOI
TL;DR: In this article, the authors provide the latest update to the EASL Clinical Practice Guidelines on the use of non-invasive tests for the evaluation of liver disease severity and prognosis.

428 citations